Rivaroxaban had a greater risk of any bleeding event than VKA, with borderline significance (RR, 1.19 [95% CI, 0.99–1.43]).
← all excerpts
Efficacy and Safety of Direct Oral Anticoagulants for Stroke Prevention in Older Patients With Atrial Fibrillation: A Network Meta-Analysis of Randomized Controlled Trials.
1
—
—